The potentiating effect of LPS on tumor necrosis factor-alpha production by influenza A virus-infected macrophages
Related Experiment Videos
A Bender1, H Sprenger, J H Gong
1Institute of Immunology, Philipps University, Marburg, Germany.
Abstract:
Infection of murine PU5-1.8 macrophages and human monocytes by influenza A virus was associated with virus replication, release of tumor necrosis factor-alpha (TNF-alpha) and subsequent cell death. In the presence of small and by itself rather inefficient concentrations of lipopolysaccharide (LPS) or free lipid A (1 to 10 ng/ml), TNF-alpha production of virus-infected macrophages was strongly potentiated. LPS-triggered and enhanced TNF-alpha release from virus-infected macrophages was neither due to increased cell survival nor altered virus replication, potentiated TNF-alpha gene transcription, release of intracellularly stored TNF-alpha or shifts in the kinetics of TNF-alpha secretion. Influenza A virus infection alone induced a massive TNF-alpha mRNA accumulation which, however, was only weakly translated into bioactive TNF-alpha protein. When these virus-primed macrophages were exposed to LPS either simultaneously or up to 4 h after infection, an efficient and high translation into TNF-alpha protein occurred. Although the LPS-induced biochemical pathways leading to an augmented TNF-alpha production by virus-infected macrophages still remains unsolved, the findings suggest that the frequently observed serious clinical complications in the course of combined influenza A virus and bacterial infections may be due, at least in part, to an excessive release of cytokines such as TNF-alpha.
Insights
Influenza A virus infection potentiates tumor necrosis factor-alpha (TNF-alpha) production in macrophages when combined with lipopolysaccharide (LPS). This enhanced TNF-alpha release may explain severe complications in co-infections.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Influenza A virus infection in macrophages leads to cell death via tumor necrosis factor-alpha (TNF-alpha) release.
- Lipopolysaccharide (LPS) can enhance TNF-alpha production, but its interaction with viral infections is complex.
Purpose of the Study:
- To investigate the combined effect of influenza A virus infection and LPS on TNF-alpha production in macrophages.
- To elucidate the mechanisms underlying enhanced TNF-alpha release in co-infected cells.
Main Methods:
- Infection of murine PU5-1.8 macrophages and human monocytes with influenza A virus.
- Treatment of infected cells with varying concentrations of LPS or lipid A.
- Measurement of TNF-alpha production, mRNA levels, and protein translation.
Main Results:
- Influenza A virus infection alone caused significant TNF-alpha mRNA accumulation but limited protein translation.
- Low concentrations of LPS strongly potentiated TNF-alpha protein release from virus-infected macrophages.
- Enhanced TNF-alpha production was not due to increased cell survival, altered virus replication, or changes in gene transcription or secretion kinetics.
Conclusions:
- Influenza A virus primes macrophages for enhanced TNF-alpha protein synthesis upon subsequent LPS exposure.
- The findings suggest that excessive TNF-alpha release in combined viral and bacterial infections contributes to severe clinical complications.